Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cancer Cell

Topics

Biology

Cancer Oncology

Chemistry

Medicine

Molecular Biology

Show all topics

DOI

10.1016/j.ccr.2010.11.023

License

publisher-specific-oa